share_log

MPX International Announces that its Malta Subsidiary, Alphafarma Operations Ltd., Receives its Medical Cannabis License

Benzinga Real-time News ·  Apr 25, 2022 14:58


TORONTO, ONTARIO –TheNewswire -April 20, 2022 –MPX International Corporation("MPX International", "MPXI" or the "Corporation")(CSE:MPXI);(OTC:MPXOF),a multinational diversified cannabis company, is pleased to announce that its Maltese indirect subsidiary, Alphafarma Operations Ltd. ("Alphafarma") has received its License for the Production of Cannabis for Medicinal and Research Purposes (the "Medical CannabisLicense") issued by the Malta Medicines Authority.  This follows the attainment of the European Union Good Manufacturing Practice certification (the "EU-GMP Certification") issued by the Medicines Authority of Malta in January 2022.

The receipt of the Medical Cannabis License is the final requirement for Alphafarma to begin commercial...

Login or create a forever free account to read this news
Sign up/Log in
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment